Full-Time

Oncology Advanced Practice Provider

Inpatient

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

10,001+ employees

Teaching hospital delivering patient-centered medical care

Compensation Overview

$129.6k - $194.3k/yr

Plymouth, MA, USA

In Person

Master's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Infection Control
Nursing
Patient Care

Get referred to Beth Israel Deaconess Medical Center

See people who can refer or advise you

Requirements
  • A Master's degree in nursing.
  • One to three full-time years of post-licensure clinical nursing experience.
  • Effective verbal and written communication skills to communicate with diverse populations, including physicians, employees, patients, and families.
  • Leadership skills to direct others toward the successful treatment of patients.
  • Analytical skills to evaluate patient status and healthcare procedures and techniques and to monitor quality of care.
  • Fiscal skills to monitor and control costs and revenue.
  • Willingness to learn and remain flexible in the changing healthcare environment.
  • Ability to assist staff in times of crisis or emergency.
  • Ability to conceptualize, develop, and implement new ideas or systems.
  • Ability to exercise sound judgment and discretion while performing duties.
  • Ability to meet with the public outside the institution and efficiently market and promote cancer treatment.
  • Ability to determine work priorities, assign work, and ensure proper completion of work assignments.
  • A license and current registration to practice in the state.
  • Graduation from a registered nurse practitioner program.
  • Ability to perform frequent bending, carrying, pulling, pushing, reaching, standing, stooping, walking, and lifting over 10 pounds, with occasional stair climbing and lifting in excess of 50 to 100 pounds.
  • Constant use of hearing, sight, and speech; frequent use of smell and touch; frequent keyboard and telephone use; and constant concentration and problem solving.
  • Current influenza vaccination as a condition of employment.
Responsibilities
  • Assess the physical and psychosocial status of clients through interviews, health histories, physical examinations, and diagnostic studies.
  • Recognize deviations from normal physical assessment findings and collaborate with physicians to formulate treatment plans and follow-up care.
  • Write prescriptions for medications and blood products, and order routine diagnostic and follow-up studies, therapeutic measures, and post-discharge care in accordance with written practice protocols.
  • Determine patient eligibility for entry into clinical trials based on clinical findings.
  • Request written consultations from physicians and other healthcare professionals to ensure appropriate and quality patient care.
  • Interpret and evaluate findings from studies and tests.
  • Relay appropriate patient-care information to collaborating physicians.
  • Administer therapeutic measures and obtain specimens as prescribed.
  • Evaluate the quality of care provided and recommend improvements.
  • Initiate actions to implement therapeutic plans consistent with patients' continuing healthcare needs.
  • Dictate follow-up letters to referring physicians summarizing treatment, response, and plan.
  • Maintain preventive health services, including screening, risk assessment, immunizations, Pap smears, and self-breast examinations.
  • Dictate or write patient histories, admissions, care plans, progress notes, and discharge notes.
  • Interact with program assistants and data managers to support optimal patient care.
  • Assist with family dynamics and coping mechanisms during acute and chronic phases of patient care.
  • Conduct or participate in daily multidisciplinary rounds and ensure appropriate and quality care for assigned patients.
  • Perform patient triage and determine the urgency of physician evaluation.
  • Provide symptom management for side effects related to oncologic treatment.
  • Establish relationships with professional and health-related groups within the community.
  • Share clinical expertise with professional and supportive personnel.
  • Document and report care accurately and promptly using appropriate forms and records.
  • Collaborate with other health disciplines to ensure continuity and quality of care.
  • Contribute to the nursing profession through publishing, committee involvement, educational media development, scientific inquiry, or creative approaches to quality improvement.
  • Lead family conferences.
  • Coordinate care for complex patients through multidisciplinary teams.
  • Coordinate, attend, and endorse cancer rehabilitation meetings.
  • Serve as liaison for palliative and supportive care consultations.
  • Follow infection-control, fire-safety, and departmental safety policies.
  • Attend mandatory in-services related to hospital and departmental policies and comply with state and federal regulations.
  • Practice within the legal boundaries of a nurse practitioner and follow defined responsibility, communication, and authority lines.
  • Compose standard policies and procedures for specialty areas and use standardized procedure guides to practice.
  • Maintain clinical and administrative expertise through formal and informal programs.
  • Maintain current knowledge of healthcare techniques and practices through workshops, seminars, and professional organizations.
  • Educate patients and families about disease processes and treatments.
  • Provide patients and families with information about symptom management and psychosocial responses to cancer diagnoses and related treatments.
  • Identify learning needs of nursing, medical staff, and students and implement appropriate educational programs.
  • Provide formal and informal education to staff in oncology care.
  • Educate other professionals about advanced practice roles and related care through local, regional, and national forums.
  • Precept graduate nursing students.
  • Participate in developing educational materials for patients and healthcare providers.
  • Complete billing and coding according to practice and institutional guidelines.
  • Provide advanced practice services in medical oncology, hematology, benign hematology, infusion medicine, survivorship, supportive oncology, and inpatient oncology settings as assigned.
  • Evaluate oncology-related consultations from the Emergency Department and inpatient services, develop initial assessment and management plans, and escalate complex cases to collaborating physicians when appropriate.
  • Manage assigned inpatient oncology and hematology consults, perform daily patient follow-up, and coordinate ongoing care with hospitalists, specialists, nursing, and case-management teams.
  • Coordinate safe transitions from inpatient to outpatient oncology care, including discharge planning, follow-up scheduling, treatment coordination, and communication with referring providers.
  • Provide timely evaluation and management of urgent oncology symptoms, treatment complications, and new malignancy presentations in accordance with established protocols.
  • Comply with hospital attendance guidelines regarding timely notification and promptness in reporting for duty.
Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

View

Beth Israel Deaconess Medical Center (BIDMC) serves as a teaching hospital in Boston affiliated with Harvard Medical School, offering a wide range of medical services across inpatient, emergency, outpatient, and urgent care. Its care model centers on delivering high-quality medical treatment to patients, supported by patient access initiatives like OpenNotes, which lets patients view clinicians’ notes online to improve understanding and engagement in their care. The hospital also supports education and research through its affiliation with Harvard, attracting funding for studies and training programs. BIDMC differentiates itself through its patient-centered approach, active patient engagement tools, and a broad network of urgent care centers and outpatient services that extend access to healthcare. The goal is to provide comprehensive, accessible, evidence-based medical care while advancing medical education and research.

Company Size

10,001+

Company Stage

Grant

Total Funding

$5.4M

Headquarters

Boston, Massachusetts

Founded

1996

Get referred to Beth Israel Deaconess Medical Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BIDMC won a $1.63 million NIH R01 on June 25, 2026 for ADAMTS13 research.
  • Needham patient volume doubled over ten years, supporting a new ambulatory building.
  • BIDMC expanded NeuroXT's Alzheimer's collaboration on May 26, 2026, strengthening AI-clinical research ties.

What critics are saying

  • Vita v. BIDMC, filed February 2023, alleges website data sharing with Meta and Google.
  • Unionized residents ratified a first contract July 1, 2026, raising labor costs through 2029.
  • Needham expansion and 2031 cancer-hospital construction demand capital while reimbursement stays unforgiving.

What makes Beth Israel Deaconess Medical Center unique

  • Harvard-affiliated BIDMC drives translational research, training, and specialty care from Boston.
  • OpenNotes made BIDMC a national transparency pioneer, opening all clinicians' notes.
  • Dana-Farber collaboration anchors BIDMC in the region's only dedicated adult inpatient cancer hospital.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Boston Cambridge Biotech Networks
Sep 1st, 2026
Beth Israel Deaconess plans new building in Needham as patient volume doubles

Beth Israel Deaconess plans new building in Needham as patient volume doubles

Harvard Medical Faculty Physicians
Aug 6th, 2026
BIDMC nationally recognized by U.S. News & World Report

BIDMC nationally recognized by U.S. News & world report. BIDMC has once again been recognized as a leading hospital in Boston and the nation. The hospital was nationally ranked in eight adult specialties - OBGYN (#4), diabetes and endocrinology - BIDMC and the Joslin Diabetes Center (#9), gastroenterology and GI surgery (#26), cancer care (#28), pulmonary and lung surgery (#26), geriatrics (#36 - tied), cardiology, heart, and vascular surgery (#35-tied), and neurology and neurosurgery (#31). A special congratulations to the Department of Obstetrics and Gynecology, which achieved its highest-ever placement in the US News rankings, earning the No. 4 spot nationally and securing its first top five ranking. Congratulations to all HMFP physicians and staff whose clinical excellence, dedication, and commitment to our patients, communities, and one another are reflected in these prestigious honors. Click here for full coverage.

Harvard Medical Faculty Physicians
Aug 6th, 2026
BIDMC OB/GYN Program Ranked #4 in the Nation by U.S. News & World Report

BIDMC OB/GYN program ranked #4 in the nation by U.S. News & World Report. Beth Israel Deaconess Medical Center's (BIDMC) Department of Obstetrics and Gynecology has been ranked #4 in the nation for Obstetrics & Gynecology care in U.S. News & World Report's 2026-2027 Best Hospitals rankings. The department was also recognized as Nationally High Performing in Gynecologic Cancer Surgery. "This recognition belongs to our entire department. Every day, our team brings our core values of humanity, excellence, and equity to life through the care we provide," said Blair Wylie, MD, MPH, Chair of the Department of Obstetrics and Gynecology at BIDMC. "From routine care to the most complex needs, our patients trust us to be with them at every stage of their journey. It is a privilege to care for them, and they are the reason this work and this recognition are so meaningful." The U.S. News & World Report recognition is part of a broader showing for BIDMC in this year's rankings. The hospital placed among the top 50 hospitals nationwide in eight specialties, and was named the #3 best hospital in the Boston region and #3 best hospital in Massachusetts. Across its specialties and procedures and conditions, BIDMC received 20 high-performing ratings in total. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions for this year's rankings; fewer than half earned recognition in any of the 37 areas of care assessed. To determine the Best Hospitals rankings, U.S. News analyzed each hospital's performance using objective measures such as risk-adjusted mortality rates, preventable complications, and patient experience, drawing on data from more than 800 million patient care records. More information on the U.S. News & World Report Best Hospitals rankings, including the full specialty rankings and procedures and conditions methodologies, is available at health.usnews.com/best-hospitals.

Beth Israel Deaconess Medical Center
Aug 5th, 2026
Beth Israel Deaconess Medical Center nationally recognized by U.S. News & World Report.

Beth Israel Deaconess Medical Center nationally recognized by U.S. News & World Report. August 05, 2026 BIDMC named in top three hospitals in Massachusetts. Boston, MA - Beth Israel Deaconess Medical Center (BIDMC) has been recognized for its high-quality care by U.S. News & World Report's 2026-2027 Best Hospitals edition, placing in the top 50 hospitals nationwide in eight specialties. BIDMC was ranked in the top 10 nationwide for two of those specialties: obstetrics & gynecology and diabetes & endocrinology. BIDMC was also named as the #3 best hospital in the Boston Metro Area region and #3 best hospital in Massachusetts. "Being again nationally recognized by U.S. News & World Report reflects the high-quality care teams across BIDMC provide to patients and their families," said Pete Healy, president, BIDMC & divisional president, Metro Boston, Beth Israel Lahey Health. "I am thankful for the commitment of our physicians, nurses, and staff to excellent and compassionate care." The eight specialties that BIDMC received national rankings include: * Obstetrics & Gynecology * Diabetes & Endocrinology * Gastroenterology & GI surgery * Pulmonology & Lung surgery * Cancer Care * Neurology & Neurosurgery * Heart & Vascular * Geriatrics The hospital received 20 high-performing ratings across specialties and procedures & conditions, including aortic valve surgery; colon cancer surgery; ear, nose & throat surgery; gynecological cancer surgery; heart bypass surgery; heart failure; kidney failure; leukemia, lymphoma & myeloma; lung cancer surgery; prostate cancer surgery; stroke; and urology. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions; less than half earned recognition in any of those 37 areas of care. To determine the Best Hospitals, U.S. News analyzed each hospital's performance based on objective measures such as risk-adjusted mortality rates, preventable complications and patient experience. The Best Hospitals Specialty rankings methodology and Procedures & Conditions ratings methodology measure patient outcomes using data from over 800 million records of patient care. About Beth Israel Deaconess Medical Center. Beth Israel Deaconess Medical Center is a leading academic medical center, where extraordinary care is supported by high-quality education and research. BIDMC is a teaching affiliate of Harvard Medical School, and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox. Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a healthcare system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,700 physicians and 39,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education. Director of Media Relations Sarah finlaw. Please note: The contact information above is for journalists and news media only. For patient care and all other inquiries, please contact your doctor or BIDMC directly.

Harvard Health Publishing
Jul 20th, 2026
Newly approved pill cuts LDL cholesterol levels by more than half.

Newly approved pill cuts LDL cholesterol levels by more than half. News briefs. July 20, 2026 * Reviewed by Robert H. Shmerling, MD, Senior Faculty Editor, Harvard Health Publishing; Editorial Advisory Board Member, Harvard Health Publishing A new pill that dramatically lowers harmful LDL cholesterol may be a good option for people who can't tolerate statins or who haven't lowered their LDL enough despite their current treatment with cholesterol-lowering drugs. Approved by the FDA in July 2026, enlicitide (Lipfendra) is the first oral version of a class of drugs known as PCSK9 inhibitors. These drugs work by mimicking the effect of a naturally occurring variant in the PCSK9 gene that leads to very low LDL levels. But the original drugs - which are given by injection once or twice a month - aren't widely used. Some people aren't comfortable giving themselves an injection. Also, most insurance companies won't cover the cost (which range from $200 to $500 or more per month) until a person has tried other therapies without success. Enlicitide is a daily pill that must be taken on an empty stomach with a sip of water, black coffee, or plain tea. It lowers LDL by nearly 60%, which is similar to the injectable PCSK9 drugs. Less than 10% of users experienced either dizziness or diarrhea, the two most common side effects. A month's supply will cost about $300; for now, insurance coverage remains unclear. You might also be interested in... Managing Your Cholesterol. Managing Your Cholesterol offers up-to-date information to help you or a loved one keep cholesterol in check. The report spells out what are healthy and unhealthy cholesterol levels, and offers specific ways to keep cholesterol in line. It covers cholesterol tests and the genetics of cholesterol. The report also focuses on treatments based on the latest scientific evidence, including the pros and cons of statins and other medications, and provides the lowdown on other substances advertised to lower cholesterol. Managing Your Cholesterol can also help you work with your doctor to individualize your treatment. The drug might be especially helpful for people whose LDL remains above recommended levels, despite taking cholesterol-lowering drug such as statins. The 2026 cholesterol guidelines recommend that people who've had a heart attack or stroke should aim for an LDL cholesterol of less than 55 milligrams per deciliter. The injectable PCSK9 drugs, alirocumab (Praluent) and evolocumab (Repatha), have been shown to reduce the incidence of heart attacks, strokes, and death from cardiovascular disease by up to 20% among people at high risk, over periods of up to at least five years. A similar study is currently underway to see if enlicitide offers the same benefit, with results expected in several years. Julie Corliss has been the executive editor of the Harvard Heart Letter since 2013. She also writes for the Harvard Health Letter, Harvard Women's Health Watch, and Harvard Men's Health Watch, as well as for Harvard... See Full Bio About the reviewer. Robert H. Shmerling, MD, Senior Faculty Editor, Harvard Health Publishing; Editorial Advisory Board Member, Harvard Health Publishing Dr. Robert H. Shmerling is the former clinical chief of the division of rheumatology at Beth Israel Deaconess Medical Center (BIDMC), and is a current member of the corresponding faculty in medicine at Harvard Medical School... See Full Bio Disclaimer: As a service to its readers, Harvard Health Publishing provides access to its library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.